DK1694694T3 - Replikationskompetent hepatitis C-virus samt anvendelsesfremgangsmåder - Google Patents
Replikationskompetent hepatitis C-virus samt anvendelsesfremgangsmåderInfo
- Publication number
- DK1694694T3 DK1694694T3 DK04812596.7T DK04812596T DK1694694T3 DK 1694694 T3 DK1694694 T3 DK 1694694T3 DK 04812596 T DK04812596 T DK 04812596T DK 1694694 T3 DK1694694 T3 DK 1694694T3
- Authority
- DK
- Denmark
- Prior art keywords
- virus
- methods
- well
- replication competent
- competent hepatitis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24221—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52598903P | 2003-12-01 | 2003-12-01 | |
| PCT/US2004/040120 WO2005053516A2 (en) | 2003-12-01 | 2004-12-01 | Replication competent hepatitis c virus and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1694694T3 true DK1694694T3 (da) | 2013-05-06 |
Family
ID=34652405
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04812596.7T DK1694694T3 (da) | 2003-12-01 | 2004-12-01 | Replikationskompetent hepatitis C-virus samt anvendelsesfremgangsmåder |
| DK11005809.6T DK2423216T3 (da) | 2003-12-01 | 2004-12-01 | Replikationskompetent hepatitis C-virus og fremgangsmåder til anvendelse |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK11005809.6T DK2423216T3 (da) | 2003-12-01 | 2004-12-01 | Replikationskompetent hepatitis C-virus og fremgangsmåder til anvendelse |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8026092B2 (da) |
| EP (2) | EP2423216B1 (da) |
| DK (2) | DK1694694T3 (da) |
| ES (1) | ES2415106T3 (da) |
| WO (1) | WO2005053516A2 (da) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6921634B2 (en) | 1999-12-23 | 2005-07-26 | Board Of Regents, The University Of Texas System | Replication competent hepatitus C virus and methods of use |
| KR20060120166A (ko) * | 2003-10-27 | 2006-11-24 | 버텍스 파마슈티칼스 인코포레이티드 | Ｈｃｖ ｎｓ３－ｎｓ４ａ 단백질분해효소 저항성 돌연변이 |
| DK1694694T3 (da) | 2003-12-01 | 2013-05-06 | Univ Texas | Replikationskompetent hepatitis C-virus samt anvendelsesfremgangsmåder |
| US7705138B2 (en) * | 2005-11-11 | 2010-04-27 | Vertex Pharmaceuticals Incorporated | Hepatitis C virus variants |
| WO2008125117A1 (en) * | 2007-04-13 | 2008-10-23 | Hvidovre Hospital | Cell culture system of a hepatitis c genotype 3a and 2a chimera |
| WO2008125119A1 (en) * | 2007-04-13 | 2008-10-23 | Hvidovre Hospital | Adaptive mutations allow establishment of jfh1-based cell culture systems for hepatitis c virus genotype 4a |
| AU2008246622B2 (en) * | 2007-04-27 | 2013-09-26 | Advanced Life Science Institute, Inc. | HCV gene |
| US8618275B2 (en) | 2007-05-18 | 2013-12-31 | Hvidovre Hospital | Efficient cell culture system for hepatitis C virus genotype 5A |
| WO2009080052A1 (en) | 2007-12-20 | 2009-07-02 | Hvidovre Hospital | Efficient cell culture system for hepatitis c virus genotype 6a |
| WO2010017819A1 (en) | 2008-08-15 | 2010-02-18 | Hvidovre Hospital | EFFICIENT CELL CULTURE SYSTEM FOR HEPATITIS C VIRUS GENOTYPE 7a |
| WO2010017818A1 (en) | 2008-08-15 | 2010-02-18 | Hvidovre Hospital | Efficient cell culture system for hepatitis c virus genotype 2b |
| CN102149817A (zh) * | 2008-09-12 | 2011-08-10 | 弗·哈夫曼-拉罗切有限公司 | 在细胞培养物中产生感染性丙型肝炎病毒颗粒 |
| WO2010039649A2 (en) * | 2008-10-03 | 2010-04-08 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Flavivirus-based system for production of hepatitis c virus (hcv) |
| WO2010037403A1 (en) | 2008-10-03 | 2010-04-08 | Hvidovre Hospital | Hepatitis c virus expressing reporter tagged ns5a protein |
| US8889848B2 (en) | 2011-07-06 | 2014-11-18 | Gilead Sciences, Inc. | HCV genotype 3 replicons |
| CA2840868A1 (en) | 2011-07-06 | 2013-01-10 | Gilead Sciences, Inc. | Hcv genotype 4 replicons |
| US9969979B2 (en) | 2012-08-31 | 2018-05-15 | The Governors Of The University Of Alberta | Methods for producing cells having a phenotype of a primary human hepatocytes and compositions |
| WO2015179204A1 (en) * | 2014-05-19 | 2015-11-26 | The University Of North Carolina At Chapel Hill | Replication-competent clones of hepatitis c virus genotype 1a |
| CA2962696A1 (en) * | 2014-10-01 | 2016-04-07 | National Research Council Of Canada | Animal models, cell lines and methods for screening hepatitis c virus vaccines |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9326271D0 (en) * | 1993-12-23 | 1994-02-23 | Zeneca Ltd | Expression of self-processing polyprotein in transgenic plants |
| US5766906A (en) * | 1994-07-11 | 1998-06-16 | The University Of North Carolina At Chapel Hill | Hepatitis A virus deletion mutants and vaccine formulations containing the same |
| US5912167A (en) | 1995-06-06 | 1999-06-15 | Wisconsin Alumni Research Foundation | Autocatalytic cleavage site and use thereof in a protein expression vector |
| US5874565A (en) * | 1995-08-29 | 1999-02-23 | Washington University | Nucleic acids comprising a highly conserved novel 3 terminal sequence element of the hepatitis C virus |
| US6127116A (en) * | 1995-08-29 | 2000-10-03 | Washington University | Functional DNA clone for hepatitis C virus (HCV) and uses thereof |
| US7049428B1 (en) * | 1998-03-04 | 2006-05-23 | Washington University | HCV variants |
| WO2000014263A2 (en) | 1998-09-03 | 2000-03-16 | Board Of Regents, The University Of Texas System | Recombinant hepatitis a virus (hav), hav variants, hav-based vaccines and methods of producing them |
| DE19915178A1 (de) * | 1999-04-03 | 2000-10-05 | Univ Mainz Johannes Gutenberg | Hepatitis C Virus Zellkultursystem |
| US6921634B2 (en) * | 1999-12-23 | 2005-07-26 | Board Of Regents, The University Of Texas System | Replication competent hepatitus C virus and methods of use |
| US20020155582A1 (en) * | 1999-12-23 | 2002-10-24 | Lemon Stanley M. | Replication competent hepatitis C virus and methods of use |
| AU2002225895A1 (en) * | 2000-11-07 | 2002-05-21 | Anadys Pharmaceuticals, Inc. | Hepatitis c virus constructs characterized by high efficiency replication |
| WO2002059321A2 (en) * | 2001-01-23 | 2002-08-01 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa | Hepatitis c virus replicons and replicon enhanced cells |
| US6689559B2 (en) * | 2001-11-29 | 2004-02-10 | The Research Foundation Of The State University Of New York | Efficient hepatitis C virus replicon and its use in identifying antiviral compounds |
| AU2003297038A1 (en) | 2002-12-13 | 2004-07-09 | Fox Chase Cancer Center | Replication of hepatitis c virus in non-hepatic epithelial and mouse hepatic cells |
| DK1694694T3 (da) | 2003-12-01 | 2013-05-06 | Univ Texas | Replikationskompetent hepatitis C-virus samt anvendelsesfremgangsmåder |
-
2004
- 2004-12-01 DK DK04812596.7T patent/DK1694694T3/da active
- 2004-12-01 ES ES04812596T patent/ES2415106T3/es active Active
- 2004-12-01 DK DK11005809.6T patent/DK2423216T3/da active
- 2004-12-01 US US10/580,979 patent/US8026092B2/en active Active
- 2004-12-01 EP EP11005809.6A patent/EP2423216B1/en active Active
- 2004-12-01 WO PCT/US2004/040120 patent/WO2005053516A2/en active Application Filing
- 2004-12-01 EP EP04812596A patent/EP1694694B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2415106T3 (es) | 2013-07-24 |
| WO2005053516A2 (en) | 2005-06-16 |
| EP1694694A2 (en) | 2006-08-30 |
| US20070292840A1 (en) | 2007-12-20 |
| EP1694694A4 (en) | 2007-07-25 |
| EP2423216B1 (en) | 2015-07-08 |
| WO2005053516A3 (en) | 2005-12-29 |
| EP2423216A1 (en) | 2012-02-29 |
| DK2423216T3 (da) | 2015-07-20 |
| US8026092B2 (en) | 2011-09-27 |
| EP1694694B1 (en) | 2013-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1694694T3 (da) | Replikationskompetent hepatitis C-virus samt anvendelsesfremgangsmåder | |
| IS8476A (is) | Lifrarbólgu C-veirutálmar | |
| IS8475A (is) | Lifrarbólgu C-veirutálmar | |
| ATE506104T1 (de) | Hepatitis-c-virus-hemmer | |
| DK1501921T3 (da) | Forbedrede virusrensningsmetoder | |
| CY2013029I1 (el) | Νεα παραγωγα ινσουλινης | |
| DK1663287T3 (da) | Anvendelse af modificerede cyclosporiner til behandling af HCV-sygdomme | |
| NO20054608D0 (no) | Influensavirusvaksine | |
| DE60329367D1 (de) | Verwendung bei der bekämpfung von hepatitis c virusinfektion | |
| ATE338041T1 (de) | Thiazolderivate als phosphodiesterase iv- inhibtoren | |
| DK1517697T3 (da) | Sure insulinpræparater med forbedret stabilitet | |
| NO20044137L (no) | Aminoindazolderivater, deres fremstilling og anvendelse samt mellomprodukter | |
| NO20040282L (no) | Hepatit C virus-polymerase-inhibitorer, samt anvendelse og fremgangsmåte for fremstilling derav og farmasøytisk preparat | |
| DK1904631T3 (da) | PRRS-vira, infektiøse kloner, mutanter deraf samt anvendelsesfremgangsmåder | |
| ATE500254T1 (de) | Die replikation von hiv hemmende purinderivate | |
| IS7831A (is) | Bóluefni | |
| IL172876A0 (en) | Substituted arylthiourea derivatives useful as inhibitors of viral replication | |
| DE602005023266D1 (de) | Azabenzofuransubstituierte thioharnstoffe als inhibitoren der virusreplikation | |
| DE602004012448D1 (de) | Morpholinylhaltige benzimidazole als inhibitoren der replikation von respiratory syncytial virus | |
| DK1691607T3 (da) | Anvendelse af N-arylhydrazinderivater til bekæmpelse af skadedyr | |
| DK1487828T3 (da) | Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme | |
| IS2922B (is) | Bóluefni | |
| ITAN20020056A0 (it) | Ranghinatore carrellato regolabile | |
| NO20051561D0 (no) | Vaksine | |
| FR2867877B1 (fr) | Modelisation assistee par ordinateur |